U.S. Pharmaceutical Policy In A Global Marketplace-Reference-Cited by-同舟云学术

U.S. Pharmaceutical Policy In A Global Marketplace

Published:2008-01 Issue:Suppl1 Volume:27 Page:w138-w150
ISSN:0278-2715
Container-title:Health Affairs
language:en
Short-container-title:Health Affairs

Author:

Lakdawalla Darius N.¹,Goldman Dana P.¹,Michaud Pierre-Carl¹,Sood Neeraj¹,Lempert Robert¹,Cong Ze¹,de Vries Han¹,Gutierrez Italo¹

Affiliation:

1. Darius Lakdawalla () is the director of research at the Bing Center for Health Economics at RAND in Santa Monica, California. Dana Goldman is chair and director of health economics, finance, and organization; Pierre-Carl Michaud is an associate economist, Economics and Statistics; Neeraj Sood is an economist; Robert Lempert is a senior physical scientist, Technology and Applied Sciences; and Ze Cong is an assistant policy analyst, all at RAND. Han de Vries is a policy analyst at RAND Europe in Cambridge,...

Publisher

Health Affairs (Project Hope)

Subject

Health Policy

Reference23 articles.

1. Prices And Availability Of Biopharmaceuticals: An International Comparison

2. The impact of price regulation on the launch delay of new drugs?evidence from twenty-five major markets in the 1990s

3. The impact of price regulation on the launch delay of new drugs?evidence from twenty-five major markets in the 1990s

4. The impact of price regulation on the launch delay of new drugs?evidence from twenty-five major markets in the 1990s

5. The Effect Of Regulation On Pharmaceutical Revenues: Experience In Nineteen Countries

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Health policy, price regulation, and innovation: Evidence from China’s vaccine industry;Journal of Development Economics;2024-03

2. Achieving dynamic efficiency in pharmaceutical innovation: Identifying the optimal share of value and payments required;Health Economics;2024-01-16

3. Understanding Cross-Country Differences in Health Status and Expenditures: Health Prices Matter;Journal of Political Economy;2023-08-01

4. Pharmaceutical spending and early-stage innovation in EU countries;Industry and Innovation;2022-01-27

5. Measuring the COVID-19 Mortality Burden in the United States;Annals of Internal Medicine;2021-12